Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Lally

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Schizophrenia (Heidelberg, Germany)|December 23, 2024
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flowJunyu Sun, Fernando Zelaya, Kyra-Verena Sendt, et al.
Psychopharmacology|December 2, 2019
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophreniaGrant McQueen, Aderlee Lay, John Lally, et al.
Schizophrenia Bulletin|April 14, 2021
Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode PsychosesOlesya Ajnakina, Tushar Das, John Lally, et al.
Asian Journal of Psychiatry|May 28, 2019
Tobacco smoking and nicotine dependence in first episode and established psychosisJohn Lally, Gilda Spaducci, Poonam Gardner-Sood, et al.
Psychiatry Research|October 30, 2020
Predicting onset of early- and late-treatment resistance in first-episode schizophrenia patients using advanced shrinkage statistical methods in a small sampleOlesya Ajnakina, Deborah Agbedjro, John Lally, et al.
Schizophrenia Research|August 30, 2018
Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort studyJohn Lally, Olesya Ajnakina, Nidhita Singh, et al.
Psychological Medicine|September 19, 2017
Brain-relevant antibodies in first-episode psychosis: a matched case-control studyFiona Gaughran, John Lally, Katherine Beck, et al.
Journal of Psychopharmacology (Oxford, England)|January 8, 2026
Associations between glutamate and cerebral blood flow in treatment-resistant schizophrenia during clozapine treatmentJunyu Sun, Fernando Zelaya, Kyra-Verena Sendt, et al.
Social Psychiatry and Psychiatric Epidemiology|July 7, 2017
Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 studyOlesya Ajnakina, John Lally, Marta Di Forti, et al.
BMC Psychiatry|October 18, 2013
Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trialFiona Gaughran, Daniel Stahl, Khalida Ismail, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Schizophrenia (Heidelberg, Germany)|December 23, 2024
Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flowJunyu Sun, Fernando Zelaya, Kyra-Verena Sendt, et al.
Psychopharmacology|December 2, 2019
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophreniaGrant McQueen, Aderlee Lay, John Lally, et al.
Schizophrenia Bulletin|April 14, 2021
Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode PsychosesOlesya Ajnakina, Tushar Das, John Lally, et al.
Asian Journal of Psychiatry|May 28, 2019
Tobacco smoking and nicotine dependence in first episode and established psychosisJohn Lally, Gilda Spaducci, Poonam Gardner-Sood, et al.
Psychiatry Research|October 30, 2020
Predicting onset of early- and late-treatment resistance in first-episode schizophrenia patients using advanced shrinkage statistical methods in a small sampleOlesya Ajnakina, Deborah Agbedjro, John Lally, et al.
Schizophrenia Research|August 30, 2018
Vitamin D and clinical symptoms in First Episode Psychosis (FEP): A prospective cohort studyJohn Lally, Olesya Ajnakina, Nidhita Singh, et al.
Psychological Medicine|September 19, 2017
Brain-relevant antibodies in first-episode psychosis: a matched case-control studyFiona Gaughran, John Lally, Katherine Beck, et al.
Journal of Psychopharmacology (Oxford, England)|January 8, 2026
Associations between glutamate and cerebral blood flow in treatment-resistant schizophrenia during clozapine treatmentJunyu Sun, Fernando Zelaya, Kyra-Verena Sendt, et al.
Social Psychiatry and Psychiatric Epidemiology|July 7, 2017
Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 studyOlesya Ajnakina, John Lally, Marta Di Forti, et al.
BMC Psychiatry|October 18, 2013
Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trialFiona Gaughran, Daniel Stahl, Khalida Ismail, et al.
Pageof 10